List of publications

All the publications of the C3M teams.

Export in CSV
GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death.

Authors Jacquin MA, Chiche J, Zunino B, Bénéteau M, Meynet O, Pradelli LA, Marchetti S, Cornille A, Carles M, Ricci JE

Cell death and differentiation Aug 2013

Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.

Authors Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G, Rezzonico R

Cell cycle (Georgetown, Tex.) Jul 2013

Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.

Authors Lounnas N, Rosilio C, Nebout M, Mary D, Griessinger E, Neffati Z, Chiche J, Spits H, Hagenbeek TJ, Asnafi V, Poulsen SA, Supuran CT, Peyron JF, Imbert V

Cancer letters Jun 2013

Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.

Authors Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, Allegra M, Giacchero D, Bahadoran P, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S

Molecular cancer therapeutics Jun 2013

Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines.

Authors Dufies M, Cassuto O, Jacquel A, Robert G, Auberger P

Cell cycle (Georgetown, Tex.) Jun 2013

Nepheliosyne B, a new polyacetylenic acid from the new caledonian marine sponge Niphates sp.

Authors Legrave N, Hamrouni-Buonomo S, Dufies M, Guérineau V, Vacelet J, Auberger P, Amade P, Mehiri M

Marine drugs Jun 2013

Tumor hypoxia and metabolism — towards novel anticancer approaches.

Authors Chiche J, Ricci JE, Pouysségur J

Annales d'endocrinologie May 2013

Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, Bénéteau M, Ricci JE, Desquiret-Dumas V, Procaccio V, Rötig A, Paquis-Flucklinger V

European journal of human genetics : EJHG May 2013

[New perspectives for metformin in cancer therapy].

Authors Loubière C, Dirat B, Tanti JF, Bost F

Annales d'endocrinologie May 2013

The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.

Authors Rosilio C, Lounnas N, Nebout M, Imbert V, Hagenbeek T, Spits H, Asnafi V, Pontier-Bres R, Reverso J, Michiels JF, Sahra IB, Bost F, Peyron JF

Cancer letters Apr 2013